Also categorized in BoardMoves:
Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
x hide permanently

Gilead Sciences Names Roche's O'Day as CEO and Chairman

Stock Market Today

Biopharmaceutical giant Gilead Sciences Inc. named Daniel O'Day, who heads Roche Holding AG's pharmaceuticals business, as its next CEO.  The California-based company's board...

Mentions: Gilead Sciences California Daniel O'Day